US Approves First Drug For People With Severe Form Of Fatty Liver Disease
Madrigal said the drug is set to be available to US patients in April. (Representational) Washington: The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease. Madrigal Pharmaceuticals’ Rezdiffra was shown to improve liver scarring in a clinical trial involving hundreds…
Read More “US Approves First Drug For People With Severe Form Of Fatty Liver Disease” »